DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award
Funds patient-centered lung cancer outcomes and survivorship research for defined populations, with a required lung cancer patient/survivor or caregiver advocate on the research team.
⚑ Requires inclusion of a lung cancer patient/survivor or caregiver advocate on the team · May include translational or clinical research, including pilot clinical trials · Research must address at least one FY26 LCRP Health Outcomes and Survivorship area of emphasis
Unit fits — one characterization, each unit's own rules
| IPPRA | 58 good | portfolio topic: public_health; social/behavioral work is central; funds applied research; clinical-trial/biomedical core — IPPRA angle is policy/community (capped) |
| Physical Sciences & Engineering (demo) | 55 good | technical depth: minor; funds applied research |
| Tom Love Innovation Hub | 30 weak | funds applied research; deep-tech content |
Description
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.
Distinctive Features:
• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.
• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.
Apply
View on Grants.gov → CONTACT: Danielle Reckley Grantor <help@eBRAP.org>